Table 1.
Total | RECIST Only | RECIST and PET | PET Only | |
---|---|---|---|---|
(n = 77) | (n = 34) | (n = 29) | (n = 14) | |
Mean age, years (range) | 60 (37–87) | 59 (44–87) | 60 (37–79) | 62 (45–76) |
Sex, n (%) | ||||
Female | 75 (97) | 33 (97) | 29 (100) | 13 (93) |
Male | 2 (3) | 1 (3) | 0 | 1 (7) |
Race, n (%) | ||||
White | 68 (88) | 29 (85) | 25 (86) | 14 (100) |
Asian | 3 (4) | 1 (3) | 2 (7) | 0 |
Black/African American | 3 (4) | 3 (9) | 0 | 0 |
Other | 2 (3) | 0 | 2 (7) | 0 |
Unknown | 1 (1) | 1 (3) | 0 | 0 |
Disease location at enrollment, n (%) | ||||
Visceral tumor | 57 (74) | 29 (85) | 26 (90) | 2 (14) |
Bone metastasis | 24 (31) | 6 (18) | 11 (38) | 7 (50) |
Median No. of prior therapies in metastatic setting (range) | 3 (0–11) | (0–9) | 2 (0–11) | 2 (0–7) |
Median time from first metastasis to enrollment, years (range) | 2.3 (0.1–11.5) | 2.8 (0.3–11.5) | 2.0 (0.2–10.8) | 1.4 (0.1–3.6) |
Abbreviations: PRC, PET Response Criteria; RECIST, Response Evaluation Criteria in Solid Tumors.